Rabeprazole and Cefdinir drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Rabeprazole (rabeprazole sodium) and Cefdinir (cefdinir). Common drug interactions include tubulointerstitial nephritis among females and colitis among males.
The phase IV clinical study analyzes what interactions people have when they take Rabeprazole and Cefdinir. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.
What is Rabeprazole?
Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.
What is Cefdinir?
Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.
55 people who take Rabeprazole and Cefdinir together, and have interactions are studied.

What are the common drug interactions of Rabeprazole and Cefdinir, by gender? *:
female:
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Upper respiratory tract inflammation
- Rash
- Cellulitis (infection under the skin)
- Pain
- Infusion related reaction
- Interstitial lung disease
- Alanine aminotransferase increased
- Ascites (accumulation of fluid in the abdominal cavity)
- Aspartate aminotransferase increased
male:
- Colitis (inflammation of colon)
- Pneumonia
- Nausea (feeling of having an urge to vomit)
- Oedema (fluid collection in tissue)
- Oesophageal adenocarcinoma (a cancer tumour of an epithelium in oesophagus)
- Rash
- Stomatitis (inflammation of mucous membrane of mouth)
- Interstitial lung disease
- Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
- Asthenia (weakness)
What are the common drug interactions of Rabeprazole and Cefdinir, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Appendicitis (inflammation of the appendix)
- Back pain
- Cystitis (inflammation of the wall of the bladder)
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
- Dyslipidaemia (abnormal amount of lipids)
- Gastroenteritis (inflammation of stomach and intestine)
- Hyperlipidaemia (presence of excess lipids in the blood)
- Lupus nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue)
- Myalgia (muscle pain)
30-39:
n/a
40-49:
- Back pain
- Diarrhoea
- Headache (pain in head)
- Herpes simplex (herpes simplex is a common viral infection)
- Nasopharyngitis (inflammation of the nasopharynx)
- Nausea (feeling of having an urge to vomit)
- Pain
- Pain in extremity
- Pain in jaw
- Plantar fasciitis (painful inflammatory process of the plantar fascia)
50-59:
- Colitis (inflammation of colon)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Pneumonia viral
- Blood lactate dehydrogenase increased
- C-reactive protein increased
- Gastric dysplasia (stomach with abnormality of development)
- Herpes zoster
- Liver disorder (liver diseases)
- Lymphocyte count decreased
- Lymphopenia (an abnormally low level of lymphocytes in the blood)
60+:
- Rash
- Cellulitis (infection under the skin)
- Aspartate aminotransferase increased
- Blood bilirubin increased
- Dysarthria (speech disorder)
- Hepatic atrophy (liver is decreased in size)
- Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
- Hepatitis acute
- Hyperammonaemia
- Insomnia (sleeplessness)
What are the existing conditions these people have? *
- Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 24 people, 43.64%
- Rashes (redness): 18 people, 32.73%
- Constipation: 17 people, 30.91%
- Insomnia (sleeplessness): 14 people, 25.45%
- Fever: 9 people, 16.36%
- Hot Flush (sudden feelings of heat): 8 people, 14.55%
- Interstitial Lung Disease: 8 people, 14.55%
- Abdominal Distension: 7 people, 12.73%
- Nausea And Vomiting: 7 people, 12.73%
- Anal Erosion: 7 people, 12.73%
* Approximation only. Some reports may have incomplete information.
Do you take Rabeprazole and Cefdinir?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Rabeprazole (31,689 reports)
- Cefdinir (9,210 reports)
Browse all drug interactions of Rabeprazole and Cefdinir:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rabeprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cefdinir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rabeprazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cefdinir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on rabeprazole sodium and cefdinir (the active ingredients of Rabeprazole and Cefdinir, respectively), and Rabeprazole and Cefdinir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drospirenone And Ethinyl Estradiol vs. Ortho Cyclen-21, side effect and effectiveness comparison - a second ago
- Drug interactions of Incruse Ellipta and Tobramycin - 3 seconds ago
- Drug interactions of Tramadol and Theophyl - 5 seconds ago
- Drug interactions of Rimifon and Furosemide - 8 seconds ago
- Drug interactions of Bethkis and Prilosec - 12 seconds ago
- Drug interactions of Oxybutynin Chloride and Niaspan - 21 seconds ago
- Drug interactions of Cromolyn Sodium and Temazepam - 21 seconds ago
- Could Azactam cause Pulmonary Oedema? - 23 seconds ago
- Felodipine vs. Prinzide, side effect and effectiveness comparison - 27 seconds ago
- Could Cromolyn Sodium cause Bronchospasm Aggravated? - 30 seconds ago